|
NBTX Nanobiotix Sa 1760854 |
| Income Statement |
|
Revenue
|
f6k_031725
|
9,289,000 |
|
Net Income
|
f6k_031725
|
-21,872,000 |
|
Profit Margin
|
|
-235.46% |
| Balance Sheet |
|
Current Assets
|
80,456,000 |
|
Assets
|
86,680,000 |
|
Current Liabilities
|
56,516,000 |
|
Liabilities
|
108,457,000 |
|
Equity
|
-21,777,000 |
|
Shares Out
|
47,133,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-5,836,000 |
|
Investing Cash Flow
|
-500,000 |
| Market Analysis |
Market Cap
|
226,755,687 |
|
Price
|
3.71 |
|
BVPS
|
2.39 |
|
PB
|
1.63 |
|
EPS
|
-1.19 |
|
PS
|
24.41 |
|
FCF
|
-6,336,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view NBTX documents filed with the SEC.
NBTX Filings
Clear
